Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03059420 · ClinicalTrials.gov registry record
Genetic Studies of Strabismus, Congenital Cranial Dysinnervation Disorders (CCDDs), and Their Associated Anomalies
A clinical trial of Congenital Fibrosis of Extraocular Muscles and Duane Retraction Syndrome, sponsored by Boston Children's Hospital.
- Recruiting
- Registry status
- 20,000
- Enrollment target
- 1
- Study location
NCT03059420 is a study of Congenital Fibrosis of Extraocular Muscles and Duane Retraction Syndrome that is actively recruiting participants, run by Boston Children's Hospital. The registered enrollment target is 20,000 participants. The trial reports 1 study location across 1 state.
The verdict
NCT03059420, a study of Congenital Fibrosis of Extraocular Muscles and Duane Retraction Syndrome, is actively recruiting participants, sponsored by Boston Children's Hospital.
- RECRUITING
- Registry status
- 20,000 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to identify genes associated with impaired development and function of the cranial nerves and brainstem, which may result in misalignment of the eyes (strabismus) and related conditions.
Conditions Studied
Study Locations (1)
Massachusetts
- Boston Children's Hospital - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20,000 participants |
| Start Date | 2004-02-01 |
| Est. Completion | 2030-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03059420
The ClinicalTrials.gov registry entry for NCT03059420 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 20,000 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Boston Children's Hospital, which has 462 total studies on file at ClinicalTrials.gov.
The record links to 10 conditions, with Congenital Fibrosis of Extraocular Muscles appearing as the primary indexed condition, and to 0 interventions.
NCT03059420 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.
Frequently Asked Questions
What is clinical trial NCT03059420 about?
NCT03059420 is a clinical study titled "Genetic Studies of Strabismus, Congenital Cranial Dysinnervation Disorders (CCDDs), and Their Associated Anomalies". The purpose of this study is to identify genes associated with impaired development and function of the cranial nerves and brainstem, which may result in misalignment of the eyes (strabismus) and related conditions.
What is the current status of trial NCT03059420?
This trial is currently recruiting. The enrollment target is 20,000 participants. The study started on 2004-02-01. Estimated completion is 2030-01.
What conditions does trial NCT03059420 study?
This clinical trial studies the following conditions: Congenital Fibrosis of Extraocular Muscles, Duane Retraction Syndrome, Duane Radial Ray Syndrome, Mobius Syndrome, Brown Syndrome.
Who is sponsoring clinical trial NCT03059420?
This trial is sponsored by Boston Children's Hospital, which has 462 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03059420 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Explore more on PlainTrial
Congenital Fibrosis of Extraocular Muscles
All registered trials for this condition
Duane Retraction Syndrome
All registered trials for this condition
Massachusetts
All trials with a study site in Massachusetts
Recruiting now
Find trials open to new participants near you
Rankings
Top sponsors, conditions, and phases
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.